Application of Human Augmentics: A Persuasive Asthma Inhaler
[Display omitted] •The design used a tailored health intervention with persuasive technology.•The method used a mobile device and app to persuade toward adherence.•A pilot study showed an 83% completion rate for improved adherence.•The study showed 58% of participants achieving clinically important...
Saved in:
Published in: | Journal of biomedical informatics Vol. 67; pp. 51 - 58 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Elsevier Inc
01-03-2017
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [Display omitted]
•The design used a tailored health intervention with persuasive technology.•The method used a mobile device and app to persuade toward adherence.•A pilot study showed an 83% completion rate for improved adherence.•The study showed 58% of participants achieving clinically important improvement.•This method was feasible to improve adherence to asthma control medication.
This article describes a tailored health intervention delivered on a mobile phone platform, integrating low-literacy design strategies and basic principles of behavior change, to promote increased adherence and asthma control among underserved minority adolescents. We based the intervention and design principles on theories of Human Augmentics and the Elaboration Likelihood Model. We tested the efficacy of using electronic monitoring devices that incorporate informative and persuasive elements to improve adherence to a prescribed daily medication regimen intended to reduce use of asthma rescue medications. We describe the theoretical framework, hardware and software systems, and results of user testing for design purposes and a clinical pilot study incorporating use of the device and software by the targeted population. The results of the clinical pilot study showed an 83% completion rate for the treatment as well as improved adherence. Of note, 8% and 58% of participants achieved clinically significant adherence targets at baseline and last week of the study, respectively. Rescue asthma medication use decreased from a median of 3 puffs per week at baseline to 0 puffs per week during the last week of the study. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1532-0464 1532-0480 |
DOI: | 10.1016/j.jbi.2017.02.003 |